Atlas Trials

Phase 2 Study of OTL38 for Intra-operative Imaging of Folate Receptor-alpha Positive Ovarian Cancer

Clinical trial NCT02317705 · COMPLETED

Trial details

NCT number
NCT02317705
Sponsor
On Target Laboratories, LLC
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Ovarian Cancer
Start date
2014-12-01
Primary completion
2015-11-01
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.